BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33583097)

  • 1. Revertant somatic mosaicism as a cause of cancer.
    Inaba T; Nagamachi A
    Cancer Sci; 2021 Apr; 112(4):1383-1389. PubMed ID: 33583097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.
    Nagamachi A; Kanai A; Nakamura M; Okuda H; Yokoyama A; Shinriki S; Matsui H; Inaba T
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33373325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
    Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
    Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
    Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.
    Sahoo SS; Pastor VB; Goodings C; Voss RK; Kozyra EJ; Szvetnik A; Noellke P; Dworzak M; Starý J; Locatelli F; Masetti R; Schmugge M; De Moerloose B; Catala A; Kállay K; Turkiewicz D; Hasle H; Buechner J; Jahnukainen K; Ussowicz M; Polychronopoulou S; Smith OP; Fabri O; Barzilai S; de Haas V; Baumann I; Schwarz-Furlan S; ; Niewisch MR; Sauer MG; Burkhardt B; Lang P; Bader P; Beier R; Müller I; Albert MH; Meisel R; Schulz A; Cario G; Panda PK; Wehrle J; Hirabayashi S; Derecka M; Durruthy-Durruthy R; Göhring G; Yoshimi-Noellke A; Ku M; Lebrecht D; Erlacher M; Flotho C; Strahm B; Niemeyer CM; Wlodarski MW
    Nat Med; 2021 Oct; 27(10):1806-1817. PubMed ID: 34621053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation.
    Hockings C; Gohil S; Dowse R; Hoade Y; Mansour MR; Gale RE; Linch DC; Rao A; Payne EM
    Br J Haematol; 2020 Feb; 188(4):e53-e57. PubMed ID: 31900929
    [No Abstract]   [Full Text] [Related]  

  • 7. Gain-of-function
    Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
    Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enigma of monosomy 7.
    Inaba T; Honda H; Matsui H
    Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monosomy 7: recent progress].
    Inaba T; Nagamachi A
    Rinsho Ketsueki; 2019; 60(9):1020-1026. PubMed ID: 31597823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
    Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans.
    Buonocore F; Kühnen P; Suntharalingham JP; Del Valle I; Digweed M; Stachelscheid H; Khajavi N; Didi M; Brady AF; Blankenstein O; Procter AM; Dimitri P; Wales JKH; Ghirri P; Knöbl D; Strahm B; Erlacher M; Wlodarski MW; Chen W; Kokai GK; Anderson G; Morrogh D; Moulding DA; McKee SA; Niemeyer CM; Grüters A; Achermann JC
    J Clin Invest; 2017 May; 127(5):1700-1713. PubMed ID: 28346228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation.
    Csillag B; Ilencikova D; Meissl M; Webersinke G; Laccone F; Narumi S; Haas O; Duba HC
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27589. PubMed ID: 30565860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7.
    Ferrari T; Weber B; Pils S; Harbott J; Borkhardt A
    Ann Hematol; 2001 Feb; 80(2):72-3. PubMed ID: 11261327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of histomorphologic, cytogenetic, and genetic abnormalities in an untreated patient with MIRAGE syndrome.
    Rentas S; Pillai V; Wertheim GB; Akgumus GT; Nichols KE; Deardorff MA; Conlin LK; Li MM; Olson TS; Luo M
    Cancer Genet; 2020 Jul; 245():42-48. PubMed ID: 32619790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms.
    Lawrie A; Stevenson DA; Doig TN; Vickers MA; Culligan DJ
    Cancer Genet; 2012 Nov; 205(11):599-602. PubMed ID: 23064135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
    Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
    Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A familial
    Rahim MQ; Rahrig A; Overholt K; Conboy E; Czader M; Saraf AJ
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of heterozygous SAMD9 CRISPR/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation.
    Pera J; Castaño J; Casamitjana J; Giorgetti A; Romero-Moya D
    Stem Cell Res; 2022 Oct; 64():102906. PubMed ID: 36087523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.